Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The array of genome editing strategies based on targeted double-stranded DNA break formation have recently been enriched through the introduction of transcription activator-like type III effector (TALE) nucleases (TALENs). To advance the testing of TALE-based approaches, it will be crucial to deliver these custom-designed proteins not only into transformed cell types but also into more relevant, chromosomally stable, primary cells. Viral vectors are among the most effective gene transfer vehicles. Here, we investigated the capacity of human immunodeficiency virus type 1- and adenovirus-based vectors to package and deliver functional TALEN genes into various human cell types. To this end, we attempted to assemble particles of these two vector classes, each encoding a monomer of a TALEN pair targeted to a bipartite sequence within the AAVS1 'safe harbor' locus. Vector DNA analyses revealed that adenoviral vectors transferred intact TALEN genes, whereas lentiviral vectors failed to do so, as shown by their heterogeneously sized proviruses in target cells. Importantly, adenoviral vector-mediated TALEN gene delivery resulted in site-specific double-stranded DNA break formation at the intended AAVS1 target site at similarly high levels in both transformed and non-transformed cells. In conclusion, we demonstrate that adenoviral, but not lentiviral, vectors constitute a valuable TALEN gene delivery platform.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the CRISPR system has the potential to be delivered by lentivirus vectors, whereas TALENs do not because of their large size and repeat sequences 23 .”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“However, although attempts to express TALEN in lentiviral vectors have failed, it has been expressed successfully in adenoviral vectors [82].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., & Bonas, U. (2009) · Science · doi:10.1126/science.1178811 · Cited by 2,470 · cited 2×
“Crucially, it has been discovered that each individual RVD dictates the binding of the repeat in which it is embedded to a single nucleotide (5,6).”
BackgroundA TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098 · cited 1×
“Hitherto, designer TALEs tested in vitro and in cellula have included those with transcriptional activation or FokI nuclease domains (8,9).”
BackgroundA Simple Cipher Governs DNA Recognition by TAL Effectors
Moscou, M. J., & Bogdanove, A. J. (2009) · Science · doi:10.1126/science.1178817 · Cited by 1,988 · cited 2×
“Crucially, it has been discovered that each individual RVD dictates the binding of the repeat in which it is embedded to a single nucleotide (5,6).”
BackgroundHybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.
Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1156 · Cited by 1,889 · cited 4×
“Hitherto, designer TALEs tested in vitro and in cellula have included those with transcriptional activation or FokI nuclease domains (8,9).”
BackgroundInfluentialGenetic engineering of human pluripotent cells using TALE nucleases
Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1927 · Cited by 1,135
Xanthomonas AvrBs3 Family-Type III Effectors: Discovery and Function
Boch, J., & Bonas, U. (2010) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080508-081936 · Cited by 978 · cited 1×
“5 repeat units with circa 34 residues each (7).”
BackgroundRepeat instability: mechanisms of dynamic mutations
Pearson, C. E., Edamura, K. N., & Cleary, J. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1689 · Cited by 924 · cited 1×
“Indeed, examples of both physiological and functionimpairing processes associated with instability of tandem repeats are copious and cover virtually all biological systems from viruses and prokaryotes to eukaryotes (44-46).”
BackgroundLombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845 · cited 1×
“of transposases, homing endonucleases and zinc finger nucleases (33-36).”
BackgroundA novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
Mussolino, C., Morbitzer, R., Lütge, F., Dannemann, N., Lahaye, T., & Cathomen, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr597 · Cited by 714 · cited 2×
“A TALEN pair (Supplementary Figure S1) targeting intron 1 of the PPP1R12C locus (AAVS1 target site: 50-TCTGTCCCCTCCACCCCAC-spacer-GACAGGAT TGGTGACAGAA-30) were generated by Golden Gate cloning, as previously described (9).”
BackgroundMethodSelf-citationRepeat instability : mechanisms of dynamic mutations
Pearson, C. E. (2005) · Medical Entomology and Zoology · Cited by 711
Research works printed but not linked: 1
- Coffin JM Hughes SH Varmus HE Retroviruses 1997 NY Cold Spring Harbor Laboratory Press, Cold Spring Harbor 21433340
Cited by
Items 201–300 of 312
Grandchamp, N., Altémir, D., Philippe, S., Ursulet, S., Pilet, H., Serre, M.-C., Lenain, A., Serguera, C., Mallet, J., & Sarkis, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099649 · Cited by 11
“TALENs have an important size with repeat domains hampering their vectorization [24].”
BackgroundXiong, X., Tasan, I., Yang, C., Zhang, M., Gonzalez, G. A. H., Liu, S., Chaturvedi, P., Belmont, A. S., & Zhao, H. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00433 · Cited by 11
Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors
Perdigão, P. R. L., Gaj, T., Santa‐Marta, M., Barbas, C. F., & Gonçalves, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150037 · Cited by 12
“In particular, due to their highly repetitive nature, lentiviral vector-mediated delivery of TALEs into cells has proven challenging [39,104,105].”
BackgroundProgress and Problems with Viral Vectors for Delivery of Talens
Bergmann, T. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000096 · Cited by 11
“Single TALEN expression vectors as performed in the study by Holkers and colleagues [58] require co-infection of two vectors encoding for each part of the nuclease pair.”
MethodResultGene therapies in clinical trials
Papadopoulos, K. I., Wattanaarsakit, P., Prasongchean, W., & Narain, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100520-0.00010-2 · Cited by 13
Mojarrad, M., Qomi, S. B., & Asghari, A. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_41_19 · Cited by 12
“[15] However, it is confronting with some limitations, such as longer cDNA in comparison to ZFN (1 kb) and difficult vector cloning.[16] Furthermore, similar to ZFN, it causes off‐target breaks leading to unwanted changes and toxicity in the genome.”
BackgroundChimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors
Fang, Y., Stroukov, W., Cathomen, T., & Mussolino, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030795 · Cited by 11
“However, despite their flexibility, so far, LVs have failed to deliver intact effectors containing a TALE-based DBD due to the highly repetitive nature of these structures that impairs viral genome integrity during the replication of recombinant vector genomes [16,17].”
BackgroundMethodSelf-citationOptical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2016) · Nature · doi:10.1038/nature20003 · Cited by 12
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders
Wal, P., Aziz, N., Singh, C. P., Rasheed, A., Tyagi, L. K., Agrawal, A., & Wal, A. (2024) · Current Gene Therapy · doi:10.2174/0115665232268840231222035423 · Cited by 14
Bambal, V., Basavaraj, P. K., & Vanaja, K. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01871-2 · Cited by 14
“They have a complex interaction between their DNA-binding domain and the catalytic region of Fok-I (TALE), which is similar to ZFs (Holkers et al. 2013; Wigdahl 2014).”
Applications and advances of CRISPR/Cas9 in animal cancer model
Xu, M., Weng, Q., & Ji, J. (2020) · Briefings in Functional Genomics · doi:10.1093/bfgp/elaa002 · Cited by 11
Genome editing: applications for medicinal and aromatic plants
Rehman, S., Rehman, I. U., Jan, B., Rashid, I., Reshi, Z. A., & Ganie, A. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819590-1.00006-9 · Cited by 12
Methods of genome engineering: a new era of molecular biology
Chugunova, A. A., Донцова, О. А., & Владимирович, С. П. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916070038 · Cited by 10
“Generation of nucleases with a large number of repeating units is difficult because of recombination, which can be stimulated by high sequence similarities of individual TALE domains [79].”
BackgroundAn Optimized Protocol for Packaging Pseudotyped Integrase Defective Lentivirus
Sengupta, R., Mukherjee, C., Sarkar, N., ZhiHong, S., Lesnik, J. K., Huang, J. S., & Lü, B. (2016) · Biological Procedures Online · doi:10.1186/s12575-016-0044-z · Cited by 9
“Repeated sequences can also cause problems in transgene expression as recently reported [17].”
BackgroundPanacea in progress: CRISPR and the future of its biological research introduction
Carroll, M., & Zhou, X. (2017) · Microbiological Research · doi:10.1016/j.micres.2017.04.012 · Cited by 12
“For the purpose of comparative analysis, they targeted adenoviral TALENs to the same locus, a protocol validated by Holkers and colleagues (Holkers et al., 2013).”
BackgroundMethodDesign, Construction, and Application of Transcription Activation-Like Effectors
Deng, P., Carter, S., & Fink, K. D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9065-8_3 · Cited by 10
Wang, Y., Khan, I., Boissel, S., Jarjour, J., Pangallo, J., Thyme, S. B., Baker, D. A., Scharenberg, A. M., & Rawlings, D. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku224 · Cited by 9
“Of note, the codons of the highly repetitive RVD array sequences were diverged to reduce sequence rearrangements occurring during reverse transcription (26) thereby permitting efficient LV packaging and expression of this novel nuclease without evidence for protein degradation (data not shown).”
BackgroundRecent Advances in Preclinical Developments Using Adenovirus Hybrid Vectors
Ehrke‐Schulz, E., Zhang, W., Gao, J. J., & Ehrhardt, A. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.140 · Cited by 9
“42 In line with this latter study, a detailed protocol on how to construct and characterize AdVs for the delivery of AAVS1-specific TALENs was presented, with the objective of providing tools for integration of transgenes into a safe harbor in the host genome by HR. 43 By using these vectors…”
Enhancing Sugar Crop Resilience to Abiotic Stress Using CRISPR/Cas Tools
Pandey, H., Misra, V., Mall, A. K., Sharma, A., Hillary, V. E., & Ceasar, S. A. (2025) · Sugar Tech · doi:10.1007/s12355-025-01561-x · Cited by 9
“Advanced genome editing tools like zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) also pose design and efficacy challenges in achieving stress tolerance (Sander et al. 2011; Holkers et al. 2013).”
Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases
Jacobs, R., Singh, P., Smith, T. S., Arbuthnot, P. B., & Maepa, M. B. (2022) · Gene Therapy · doi:10.1038/s41434-022-00342-5 · Cited by 8
“Interestingly, fi rst and second generation AdVs delivered full length genomes and achieved signi fi cant disruption of the target locus [80].”
Enhanced gene disruption by programmable nucleases delivered by a minicircle vector
Dad, A.-B., Ramakrishna, S., Song, M., & Kim, S. (2014) · Gene Therapy · doi:10.1038/gt.2014.76 · Cited by 8
Genome Engineering for Therapeutic Applications
Thakore, P. I., & Gersbach, C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00003-8 · Cited by 8
Bachtarzi, H. (2017) · Regenerative Medicine · doi:10.2217/rme-2017-0095 · Cited by 7
TALEN mediated gene editing in a mouse model of Fanconi anemia
Pino-Barrio, M. J., Gimenez, Y. A., Villanueva, M., Hildenbeutel, M., Sánchez‐Domínguez, R., Rodríguez, S., Pujol, R. M., Surrallés, J., Río, P., Cathomen, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63971-z · Cited by 8
Self-citationThe genome editing revolution: A CRISPR-Cas TALE off-target story
Stella, S., & Montoya, G. (2015) · Inside the Cell · doi:10.1002/icl3.1038 · Cited by 8
Ferreira, D., & Martins, I. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100741-9.00015-2 · Cited by 7
Nicholson, S., Moyo, B., & Arbuthnot, P. B. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i6.859 · Cited by 5
Development of smart fruit crops by genome editing
Butiuc-Keul, A. L., Farkas, A., Carpa, R., DOBROTA, C. T., & Iordache, D. (2022) · TURKISH JOURNAL OF AGRICULTURE AND FORESTRY · doi:10.55730/1300-011x.2965 · Cited by 9
“TALENs design is easier, but homologous recombination in vivo may occur due to the highly repetitive sequences (Holkers et al., 2013).”
BackgroundAssembly and Characterization of megaTALs for Hyperspecific Genome Engineering Applications
Boissel, S., & Scharenberg, A. M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1862-1_9 · Cited by 6
The Synergy between CRISPR and Chemical Engineering
Lau, C., & Tin, C. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190701100556 · Cited by 5
Engineering Sequence-Specific DNA Binding Proteins for Antiviral Gene Editing
Arbuthnot, P. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-410518-8.00003-x · Cited by 6
Optimizing Delivery and Expression of Designer Nucleases for Genome Engineering
Chuah, M., & VandenDriessche, T. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.166 · Cited by 6
“Ad vectors are also well suited for TALEN gene delivery in transformed and nontransformed cells (Holkers et al. , 2013).”
Harnessing CRISPR/Cas-mediated genetic innovations in lepidopteran insects
Geerthana, S., Suresh, K., Prabhakar, N., Rani, B. U., Thangaraj, K., Paramasivam, M., Kumar, A., Asokan, R., & Ashok, K. R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146574 · Cited by 5
Targeted Mitochondrial Genome Elimination
Bacman, S. R., Pereira, C. V., & Moraes, C. T. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_24 · Cited by 4
6. Themenbereich somatische Gentherapie: Translationale und klinische Forschung
Fehse, B., & Domasch, S. (2015) · Nomos Verlagsgesellschaft mbH & Co. KG eBooks · doi:10.5771/9783845246956-210 · Cited by 5
Genome Editing with Targetable Nucleases
Pelletier, S. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-34148-4_1 · Cited by 5
Genome-editing Technologies and Patent Landscape Overview
Benahmed-Miniuk, F., Kresz, M., Kanaujiya, J. K., & Southgate, C. D. (2017) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2017-0004 · Cited by 5
TALEN-induced contraction of CTG trinucleotide repeats in myotonic dystrophy type 1 cellsPreprint
Bétemps, L., Descorps-Declère, S., Frenoy, O., Poggi, L., Mosbach, V., Tomé, S., Viterbo, D., Klein, A. F., Ma, L., Lameiras, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.14.562330 · Cited by 5
“This observation mirrored what had been previously described for TALENs expressed from lentiviruses (Holkers et al , 2013).”
BackgroundResultKhalid, S., Shahid, M. N., Nawaz, K., Naeem, M., & Jabeen, K. (2025) · CABI eBooks · doi:10.1079/9781800622517.0004 · Cited by 3
Applications of genome editing technologies in the treatment of human diseases
Alshorman, J., Mehran, M. J., Tembo, K. M., Mostafavi, N., Bolideei, M., & Wang, Y. L. (2026) · Gene Therapy · doi:10.1038/s41434-026-00627-z · Cited by 4
Genome editing tools: principles, structures, and mechanisms
Naik, R. A., Mir, M. N., Rajpoot, R., Singh, S. R., Singh, K., & Singh, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23826-0.00012-x · Cited by 3
Excision of HIV-1 Provirus in Human Primary Cells with Nanocapsuled TALEN Proteins
Zhao, M., Wen, J., Chen, I. S. Y., Liu, J., & Lu, Y. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01544 · Cited by 4
Self-citationPerspectives of Genome-Editing Technologies for HIV Therapy
Ebina, H., Gee, P., & Koyanagi, Y. (2015) · Current HIV Research · doi:10.2174/1570162x13666150807105718 · Cited by 4
Techniques and strategies employing engineered transcription factors
Lawson, S., & Bleris, L. G. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.10.009 · Cited by 4
Ramakrishnaiah, T. N., Ramachandregowda, S., Muktha, H., Surendra, A. S., Tanvi, Y., Srikar, K. S., & Rajashekara, S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106798 · Cited by 4
Genetic Engineering of Plants Using Zn Fingers, TALENs, and CRISPRs
Bilichak, A., & Eudes, F. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00012-4 · Cited by 3
Genome editing for the treatment of tumorigenic viral infections and virus-related carcinomas
Yu, L., Tian, X., Gao, C., Wu, P., Wang, L., Feng, B., Li, X., Wang, H., Ma, D., & Hu, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0572-1 · Cited by 3
“Lentivirus holds a larger delivery capacity than that of AAV; hence, TALENs or CRISPR/Cas9 are deliverable by lentiviral vectors [91,92].”
BackgroundInfluentialEngineering synthetic optogenetic networks for biomedical applications
Wang, M., Yu, Y., Shao, J., Heng, B. C., & Ye, H. (2017) · Quantitative Biology · doi:10.1007/s40484-017-0105-6 · Cited by 3
“A Grm2-targeted LITE was applied into primary cortical neurons by adeno-associated viruses (AAVs) [95,101], which upregulated Grm2 mRNA and mGluR2 protein levels after light stimulation.”
MethodKey to Delivery: The (Epi-)genome Editing Vector Toolbox
Just, S., & Büning, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7774-1_7 · Cited by 3
Transgenic horticultural crops for combating abiotic stresses
Tiwari, V., & Charuvi, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822849-4.00006-1 · Cited by 3
Understanding CRISPR/Cas9: A Magnificent Tool for Plant Genome Editing
Ricaño-Rodríguez, J., Suárez-Medellín, J. M., Vásquez, E. C., Ramos-Prado, J. M., & Hipólito-Romero, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81080 · Cited by 3
“Thus, DSBs with 50-extensions originate [31, 34, 35].”
Josephine, A., Kumar, T. S., Ashok, K. S., Dharani, G., & Kirubagaran, R. (2025) · International Journal on Algae · doi:10.1615/interjalgae.v27.i3.70 · Cited by 2
The convergence of synthetic biology and metagenomics: Current advances and future perspectives
Maqbool, M., Haque, E., Thacharodi, A., Meenatchi, R., Arafath, A. Y., Fathima, S. A., Genevieve, K. K., Singh, T., Rajalakshmi, D., Nisha, K., et al. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102506 · Cited by 4
Variations on a Theme: Crispr Models for 15q11-Q13 Disorders and Beyond
Bailus, B. J. (2014) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000146 · Cited by 2
“TALENS appear to be more specific then ZFN, however they are complicated to create and unlike the CRISPR system two TALENs are needed per desired mutation site, requiring several plasmids/viral vectors for a multiple gene disorder model [39-43].”
BackgroundTechnologies for crop improvement
Hull, R., Head, G., & Tzotzos, G. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818564-3.00002-0 · Cited by 3
Genome-Editing Technologies in Crop Improvement
Das, R., Kumar, P., Agrawal, S., Singh, K., Singh, N., Singh, S., Singh, A. K., Rajput, V. D., Shukla, P. K., Minkina, T., et al. (2024) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-99-9338-3_4 · Cited by 2
Cystic fibrosis therapy: from symptoms to the cause of the disease
Kireeva, T. N., Жигалина, Д. И., & Skryabin, N. A. (2025) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-25-31 · Cited by 5
Enríquez, P. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.79564 · Cited by 3
“The highly repetitive sequences associated with TALE tandem repeats make them susceptible to rearrangements when expressed in target cells due to recombination events that trigger deletions [32].”
BackgroundCellular Engineering and Disease Modeling with Gene-Editing Nucleases
Osborn, M. J., & Tolar, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_12 · Cited by 3
Gene Editing in Adult Hematopoietic Stem Cells
López-Manzaneda, S., Fañanas-Baquero, S., Nieto-Romero, V., Roman‐Rodriguez, F. J., Fernández-García, M., Pino-Barrio, M. J., Rodríguez-Fornés, F., Díez, B., García-Bravo, M., Navarro, S., et al. (2016) · InTech eBooks · doi:10.5772/62383 · Cited by 2
“highly repetitive structures make these sequences hard to package into viral vectors because of their tendency to recombine (82).”
Zárate, R. V., Arancibia, D., Fernandez, A., Signorelli, J. R., Larrondo, L., Andrés, M., & Zamorano, P. (2021) · Electronic Journal of Biotechnology · doi:10.1016/j.ejbt.2021.03.006 · Cited by 2
Use of CRISPR/Cas System to Create Resistance to Cotton Diseases
Bukhari, S. A. R., Saeed, M., & Briddon, R. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-64504-5_15 · Cited by 3
Optical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2016) · Nature · doi:10.1038/nature20002 · Cited by 2
Recent advances in Medicago spp . genetic engineering strategies
Confalonieri, M., & Sparvoli, F. (2019) · Wiley eBooks · doi:10.1002/9781119409144.ch149 · Cited by 2
Gene-Edited Cell Models to Study Chronic Wasting Disease
Thapa, S., Marrero-Winkens, C., Tahir, W., Arifin, M. I., Gilch, S., & Schätzl, H. M. (2022) · Viruses · doi:10.3390/v14030609 · Cited by 1
Strategies to eliminate native T cell receptors for adoptive T cell therapies
Flumens, D., Campillo-Davó, D., Oers, F. V., Shaw, P. A. G., & Lion, E. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.01.017 · Cited by 1
“71,72 Notably, stable expression of designer nucleases is neither required nor desirable, as prolonged nuclease activity increases the risk of off-target effects.”
The future of pediatric gene therapy: CRISPR-Cas9, AI, and personalized medicine
Pan, Y., Ding, J., Wang, W., Xu, D., Fan, J., & Zhang, W. (2026) · Pediatric Research · doi:10.1038/s41390-026-05270-3 · Cited by 2
Editing Cultured Human Cells: From Cell Lines to iPS Cells
Li, H. L., & Hotta, A. (2014) · Springer eBooks · doi:10.1007/978-4-431-55227-7_3 · Cited by 1
The Use and Development of TAL Effector Nucleases
Juillerat, A., Duchateau, P. N., Cathomen, T., & Mussolino, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_3 · Cited by 1
Self-citationCellular Therapies: Gene Editing and Next-Gen CAR T Cells
Cradick, T. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-29827-6_9 · Cited by 1
Modeling Cancer Using CRISPR-Cas9 Technology
Rodríguez, S., Martínez-Lage, M., & Torres-Ruiz, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00034-6 · Cited by 3
Targeted Porcine Genome Engineering with TALENs
Luo, Y., Lin, L., Golas, M. M., Sørensen, C. B., & Bolund, L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2389-2_2 · Cited by 1
Targeted Genome-Editing Techniques in Plant Defense Regulation
Dixit, V., & Upadhyay, P. (2022) · Springer eBooks · doi:10.1007/978-3-031-12990-2_1 · Cited by 2
Genome Editing: A Review of the Challenges and Approaches
Sharma, D., Kaur, H., Kapoor, H. K., Sharma, R., Kaur, H., & Kyum, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-08072-2_4 · Cited by 1
Therapeutic targeting non-coding RNAs
Ray, R. M., Lazăr, A. D., Balahura, L.-R., Dobranici, A., Costache, M., & Dinescu, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90406-3.00006-3 · Cited by 2
Genome Editing: Current Approaches and the Road Ahead in Cancer Research and Therapeutics
Athanasopoulou, K., Daneva, G. N., Adamopoulos, P. G., & Scorilas, A. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_269 · Cited by 1
Molecular and Genetic Medicine
Bergmann, T., Ehrke‐Schulz, E., & Ehrhardt, A. (2014) · Cited by 1
Using Engineered Nucleases to Create HIV-Resistant Cells
Llewellyn, G. N., Exline, C. M., Holt, N. G., & Cannon, P. M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-3509-3_10 · Cited by 1
Engineering of Human-Induced Pluripotent Stem Cells for Precise Disease Modeling
Lisowski, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_15 · Cited by 1
Exploring the potential of CRISPR-Cas9 for the removal of human viruses
Panchasara, H., Patel, S. K., & Singh, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818140-9.00003-9 · Cited by 3
Brazelton, A. (2015) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-4380 · Cited by 1
“, 2013); (Holkers et al., 2013) have held back broad adoption and use”
BackgroundEngineering Plants for Metal Tolerance and Accumulation
Tonelli, F. M. P., Tonelli, F. C. P., Lemos, M. S., Cordeiro, H. G., & Ferreira, D. R. C. (2022) · Bioresource Technology · doi:10.1002/9781119789444.ch12 · Cited by 1
Genome‐Editing Tools for Engineering of MicroRNAs and Their Encoded Peptides, miPEPs, in Plants
Kumar, R. S., Sinha, H., Datta, T., Sharma, A., & Trivedi, P. K. (2023) · Wiley eBooks · doi:10.1002/9781394183913.ch8 · Cited by 2
Synthetic Biology-Based Approaches to Enhance Transgene Attributes
Chakraborty, S. (2014) · DukeSpace (Duke University)
Function and application of TAL effectors
Li, T. (2014) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-850 · Cited by 1
Biotherapies of neuromuscular disorders
Briand, J.-F., Roy, M.-O., Mourlane, F., André, C., Loux, N., Rougeau, C., Toursel, T., & Braun, S. (2014) · Revue Neurologique · doi:10.1016/j.neurol.2014.07.018
Developing novel therapeutic strategies for Rett syndrome
Ross, P. D. (2016) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Engineering the zinc finger recombinase for use in targeted genomic editing
Kentner, J. L. (2015) · Enlighten: Theses (The University of Glasgow)
Genome Editing Tools und ihr Einsatz in der experimentellen Augenheilkunde
Yanik, M., Wende, W., & Stieger, K. (2017) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-0042-119205 · Cited by 1
“Virale Vektoren transduzieren sehr effizient ihre spezifischen Zellen, doch die Größe der TALEN sowie ihre repetitive Struktur stellt hier ein Hemmnis dar [37].”
BackgroundDetection of MegaTAL-induced HIV pol Mutation By Droplet Digital PCR
Liang, S. Y. (2015) · ResearchWorks at the University of Washington (University of Washington)
Designer Effectors for Editing and Regulating Complex Genomes
Müller, M., Mlambo, T., & Mussolino, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53457-2_7
Self-citationCRISPRs encounter Cocktail: a dawn for curing HIV/AIDS
Li, Y., Zhang, Z., Feng, H., Wang, J., Jiang, D., & Yang, K. (2017) · Virology Research and Reviews · doi:10.15761/vrr.1000123
Therapeutic gene editing in hematopoietic progenitor cells from a mouse model of Fanconi anemiaPreprint
Pino-Barrio, M. J., Gimenez, Y. A., Villanueva, M., Hildenbeutel, M., Sánchez‐Domínguez, R., Rodríguez, S., Pujol, R. M., Surrallés, J., Rı́o, P., Cathomen, T., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/362251
Self-citationGenome Editing Technologies: From Bench Side to Bedside
Tuncay, F. Y., & Dinçer, P. (2018) · Acta Medica · doi:10.32552/2018.actamedica.282 · Cited by 1
“[75] Holkers M, Maggio I, Liu J, et al.”
BackgroundEnhancing the Efficiency of CRISPR/Cas9 Precise Gene Editing for Cystic Fibrosis Gene Therapy
Seigel, K. E. (2018) · TSpace (University of Toronto)
Concepts and potential applications of gene editing in aquaculture
Pande, A., Bhat, R. A. H., Saxena, A., & Tyagi, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816352-8.00011-4 · Cited by 2
Evaluating the performance of a post-translational dynamic metabolic control system
Kadam, K., Euler, C., & Mahadevan, R. (2019) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2019.12.262
An improved lentivirus vector for safer transgene integration and protein transduction
Schenkwein, D. (2013) · UEF eRepo (University of Eastern Finland)
Wunderlich, S., Haase, A., Merkert, S., Jahn, K., Deest, M., Glage, S., Korte, W., Martens, A., Kirschning, A., Zeug, A., et al. (2021) · bioRxiv · doi:10.1101/2021.09.19.460940
Lin, C. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718045356.793484741
Metadata
- Authors
- Holkers, M., Maggio, I., Liu, J., Janssen, J. M., Miselli, F., Mussolino, C., Recchia, A., Cathomen, T., & Gonçalves, M. A. F. V.
- Affiliations
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Gonçalves, Manuel A. F. V.
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-26
- Volume
- 41
- Issue
- 5
- Pages
- e63-e63
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3597656
- OpenAlex
- W2090787765
- Cited by
- 312
- References
- 62
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 14 · 2023: 9 · 2022: 10 · 2021: 17 · 2020: 17 · 2019: 16 · 2018: 23 · 2017: 33 · 2016: 42 · 2015: 47 · 2014: 44 · 2013: 21
- FWCI
- 21.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- European Commission (222878)
- Universiteit Leiden
- Prinses Beatrix Spierfonds (W.OR11–18)
- Leids Universitair Medisch Centrum
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- TALE nucleases, adenoviral vector, lentiviral vectors, HIV-1-based vectors, AAVS1 safe harbor, genome editing, DNA double-strand breaks, primary human cells
- MeSH terms
- Adenoviridae, Bacterial Proteins, Chromosomes, Human, Deoxyribonucleases, Genetic Vectors, HeLa Cells, Humans, Transduction, Genetic, HIV-1, DNA Breaks, Double-Stranded, Genetic Loci, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.